Advanced Search
Submit Manuscript Volume 29, No 8, Aug 2019
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 29 Issue 8, August 2019: 628-640
Jlenia Guarnerio 1,8, Yang Zhang1, Giulia Cheloni1, Riccardo Panella1, Jesse Mae Katon1, Mark Simpson2, Akinobu Matsumoto1,Antonella Papa 1, Cristian Loretelli1, Andreas Petri3, Sakari Kauppinen3, Cassandra Garbutt4, Gunnlaugur Petur Nielsen5,Vikram Deshpande5, Mireia Castillo-Martin6, Carlos Cordon-Cardo6, Spentzos Dimitrios4, John G. Clohessy 1, Mona Batish 2,7 and Pier Paolo Pandolfi 1
1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA; 2Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers University, Newark, NJ 07103, USA; 3Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark; 4MGH Center for Sarcoma and Connective Tissue Oncology, Department of Orthopedic Surgery, New York, USA; 5MGH Center for Sarcoma and Connective Tissue Oncology, Department of Pathology, New York, USA; 6Department of Pathology, Mount Sinai School of Medicine, The Mount Sinai Medical Center, New York, NY 10029, USA and 7Department of Medical and Molecular Sciences, University of Delaware, Newark, DE 19716, USA
https://doi.org/10.1038/s41422-019-0192-1